Simultaneous determination of three isomeric metabolites of tacrolimus (FK506) in human whole blood and plasma using high performance liquid chromatography–tandem mass spectrometry
- 1 January 2006
- journal article
- Published by Elsevier BV in Journal of Chromatography B
- Vol. 830 (2), 330-341
- https://doi.org/10.1016/j.jchromb.2005.11.010
Abstract
No abstract availableThis publication has 25 references indexed in Scilit:
- The efficacy and safety of tacrolimus ointment: A clinical reviewJournal of the American Academy of Dermatology, 2005
- Effects of some hematological parameters on whole blood tacrolimus concentration measured by two immunoassay-based analytical methodsClinical Biochemistry, 2005
- Immunosuppressant Drug Monitoring: Is the Laboratory Meeting Clinical Expectations?Annals of Pharmacotherapy, 2005
- A review of the action of tacrolimus (FK506) on experimental models of rheumatoid arthritisInflammation Research, 2005
- TacrolimusDrugs, 2005
- Applications of tacrolimus for the treatment of skin disordersImmunopharmacology, 2000
- Tacrolimus in liver transplantationExpert Opinion on Investigational Drugs, 1999
- Newer Immunosuppressive DrugsJournal of the American Society of Nephrology, 1999
- An HPLC/MS/MS assay for tacrolimus in patient blood samples Correlation with results of an ELISA assayJournal of Pharmaceutical and Biomedical Analysis, 1997
- FK506 (Tacrolimus) and Its Immunoreactive Metabolites in Whole Blood of Liver Transplant Patients and Subjects with Mild Hepatic DysfunctionPharmaceutical Research, 1996